Lila Bio lands $3.65M grant to fight pulmonary hypertension with AI-designed proteins
Seattle startup Lila Bio received a $3.65 million NIH grant to develop an AI-designed protein treatment for pulmonary hypertension. The goal is to address the underlying disease, rather than just ease symptoms, though the research is still in the lab and…
Adjust this page to suit you. Your choices are saved in this browser.
Cookies. Chipokia uses one cookie, and only if you allow it: a random ID so your up and down votes stay yours. No analytics, no advertising, no tracking of any kind. Privacy & Cookie Policy.
